Correlation Between Pfizer and VictoryShares Value

Can any of the company-specific risk be diversified away by investing in both Pfizer and VictoryShares Value at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and VictoryShares Value into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and VictoryShares Value Momentum, you can compare the effects of market volatilities on Pfizer and VictoryShares Value and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of VictoryShares Value. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and VictoryShares Value.

Diversification Opportunities for Pfizer and VictoryShares Value

0.82

Correlation Coefficient

Pfizer  VictoryShares Value

Very poor diversification

The 3 months correlation between Pfizer and VictoryShares is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and VictoryShares Value Momentum in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VictoryShares Value and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with VictoryShares Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VictoryShares Value has no effect on the direction of Pfizer i.e., Pfizer and VictoryShares Value go up and down completely randomly.

Pair Corralation between Pfizer and VictoryShares Value

Considering the 90-day investment horizon Pfizer is expected to generate 2.77 times less return on investment than VictoryShares Value. In addition to that, Pfizer is 1.97 times more volatile than VictoryShares Value Momentum. It trades about 0.04 of its total potential returns per unit of risk. VictoryShares Value Momentum is currently generating about 0.22 per unit of volatility. If you would invest  7,770  in VictoryShares Value Momentum on May 1, 2025 and sell it today you would earn a total of  840.00  from holding VictoryShares Value Momentum or generate 10.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.39%
Values	Daily Returns

Pfizer Inc  vs.  VictoryShares Value Momentum

Pfizer Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

VictoryShares Value

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in VictoryShares Value Momentum are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, VictoryShares Value may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Pfizer and VictoryShares Value

The main advantage of trading using opposite Pfizer and VictoryShares Value positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, VictoryShares Value can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VictoryShares Value will offset losses from the drop in VictoryShares Value's long position.

The idea behind Pfizer Inc and VictoryShares Value Momentum pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.